ライフサイエンスコーパス: exercise performance

1 entation with nitrate can improve submaximal exercise performance.

2 and mode of operation do not influence early exercise performance.

3 on peripheral versus central determinants of exercise performance.

4 ovements in laboratory- and ambulatory-based exercise performance.

5 (AKG) is a metabolic signature of resistance exercise performance.

6 l disease patients with claudication-limited exercise performance.

7 d flow to limb locomotor muscles and reduces exercise performance.

8 ith an improved quality of life and improved exercise performance.

9 between members of the genus Veillonella and exercise performance.

10 t, was the primary factor in such diminished exercise performance.

11 VRS and were associated with improvements in exercise performance.

12 late the flow abnormalities to the patients' exercise performance.

13 uction in lung volumes and an improvement in exercise performance.

14 esurgence in interest surrounding the KD and exercise performance.

15 esting were closely associated with improved exercise performance.

16 d airflow turbulence, contribute to limiting exercise performance.

17 ximal ventilation, thereby improving maximal exercise performance.

18 atment for emphysema, is reported to improve exercise performance.

19 keletal muscle and local as well as systemic exercise performance.

20 AMPK deficiency in muscle reduced treadmill exercise performance.

21 port vasodilation, muscle contractility, and exercise performance.

22 ptake during submaximal exercise and enhance exercise performance.

23 emic O(2) uptake during exercise and improve exercise performance.

24 cardiac and vascular function, and worsened exercise performance.

25 the early part of the active phase improves exercise performance.

26 elationship between brain responsiveness and exercise performance.

27 ressed the contribution of liver glycogen to exercise performance.

28 ling pressures at mild exertion and improved exercise performance.

29 d wealth independently associated with lower exercise performance.

30 eflect the underlying physiological basis of exercise performance.

31 ng does not confer an improvement in maximal exercise performance.

32 intergroup differences and associations with exercise performance.

33 planation for interindividual variability in exercise performance.

34 or fourth dimension, in models of endurance exercise performance.

35 tion in the equine MSTN gene associated with exercise performance.

36 ent as exercise training but did not improve exercise performance.

37 bility, motoneuronal output and, ultimately, exercise performance.

38 en body composition, kinetic parameters, and exercise performance.

39 circadian influences on metabolic health and exercise performance.

40 utonomic control is essential for optimizing exercise performance.

41 d glucose utilization in the muscle and poor exercise performance.

42 y abrogated the positive effects of IL-37 on exercise performance.

43 nessed to alter systemic fuel metabolism and exercise performance.

44 r, increased aged muscle mass, strength, and exercise performance.

45 2+) handling in skeletal muscle and improves exercise performance.

46 ough PFO increases during exercise impairing exercise performance.

47 es for recovery and that augments subsequent exercise performance.

48 in regulating physical activity behavior and exercise performance.

49 so associated with a significant increase in exercise performance.

50 e, vigilance, symptoms, adverse effects, and exercise performance.

51 t of statins on skeletal muscle strength and exercise performance.

52 ermine if statins affect muscle strength and exercise performance.

53 s are critical regulators of skeletal muscle exercise performance.

54 mall and used crude measures of strength and exercise performance.

55 logy and improved muscle strength as well as exercise performance.

56 ised with artificial sweetener, would affect exercise performance.

57 (+)/K(+) transport in skeletal muscles or in exercise performance.

58 study and to identify factors that influence exercise performance.

59 9 (2.08-3.47), and 14.61 (10.09-21.17); poor exercise performance-1.11 (0.94-1.31), 1.58 (1.33-1.88),

60 echin treatment and regular exercise on: (1) exercise performance, (2) muscle fatigue, (3) capillarit

61 rt Physical Performance Battery), submaximal exercise performance (6-Minute Walk Test), standing bala

62 tory Questionnaire total score, >/=25), poor exercise performance (6-minute-walk distance, <391 m), b

63 and pulmonary vascular abnormalities to the exercise performance achieved.

64 Exercise performance after the Fontan procedure is reduc

65 Aerobic exercise performance also improved in both sexes, with m

66 y specific effects on short-duration maximal exercise performance and (2) discuss strategies to promo

67 ed as a putative ergogenic aid that improves exercise performance and blood buffering capacity during

68 tation is due to deconditioning, we assessed exercise performance and cardiopulmonary function in sev

69 The association between exercise performance and composite outcome was linear; t

70 ied patients; (2) the impact of HF + COPD on exercise performance and contrasting exercise responses

71 ontrolled clinical trial compared changes in exercise performance and daily ambulatory activity in pe

72 al artery disease have a marked reduction in exercise performance and daily ambulatory activity irres

73 d IMT did not produce additional benefits in exercise performance and exercise-related symptoms.

74 or these patients with the goal of improving exercise performance and functional capacity.

75 However, timing can boost or blunt exercise performance and health benefits.

76 nd well tolerated and associated with better exercise performance and health status among those most

77 In addition, they displayed poor exercise performance and impaired muscle glycogen metabo

78 ptations to training that ultimately enhance exercise performance and improve metabolic health.

79 ulation (tDCS) has been used aiming to boost exercise performance and inconsistent findings have been

80 t diet provision, loss of muscle PDH worsens exercise performance and induces lactic acidosis.

81 We examined the effects of C(aO(2)) on exercise performance and its interaction with peripheral

82 Declines in endurance exercise performance and its physiological determinants

83 a retrospective, cross-sectional analysis of exercise performance and left ventricular (LV) morpholog

84 seem to be associated with EICR and superior exercise performance and may represent a benign phenomen

85 esis, mitochondrial respiration, and reduces exercise performance and muscle force in mice.

86 auge whether modulating exercise VR enhances exercise performance and outcomes.

87 either HD-tDCS nor conventional tDCS changed exercise performance and psychophysiological responses i

88 d that beraprost would: 1) improve treadmill exercise performance and quality of life; and 2) decreas

89 We evaluated exercise performance and RM function at rest and during

90 elayed frailty onset with improved glycemia, exercise performance and strength.

91 of life because of a profound limitation in exercise performance and the potential to develop critic

92 al literature that relates to differences in exercise performance and well-being between exercising i

93 Low transplant-free survival, poor exercise performance, and accruing morbidities highlight

94 mplications for improving physical activity, exercise performance, and brain-related function and out

95 nts in quality of life, functional capacity, exercise performance, and heart failure (HF)-related hos

96 cise, identify the impact of sex hormones on exercise performance, and highlight key areas for future

97 ation is known to improve vascular function, exercise performance, and oxygen uptake, its specific im

98 muscle syntrophins has a profound effect on exercise performance, and skeletal and cardiac muscle dy

99 D36 has a key role in muscle fuel selection, exercise performance, and training-induced muscle FAO ad

100 recovered cardiac function, showed improved exercise performance, and were protected from myocardial

101 While many of the cardiac limitations to exercise performance are now well-characterized, extraca

102 n (CRC group 59.4%; control group 62.5%) and exercise performance as assessed by peak oxygen consumpt

103 Better endurance exercise performance associated with greater LVM was not

104 ercise capacity that is predictable based on exercise performance at SL.

105 tigators assessed the quality of Chinese eye exercises performance at the end of the follow-up period

106 asingly popular for improving high-intensity exercise performance because it is the rate-limiting pre

107 s utilized to compare the difference in each exercise performance between groups adjusting for age, s

108 There were no significant differences in exercise performance between groups as assessed by peak

109 utilization to improve cardiac function and exercise performance beyond standard care.

110 ivates regions of the brain that can enhance exercise performance but direct evidence of such a mecha

111 ive ventilation reduces dyspnea and improves exercise performance, but current systems are unsuitable

112 Enalapril treatment did not influence exercise performance, but did reduce LVESWS in the first

113 to an inflammatory challenge, also improved exercise performance by 82% compared with vehicle-treate

114 a gut-brain connection in mice that enhances exercise performance by augmenting dopamine signalling d

115 g with blood flow restriction (BFR) improves exercise performance by enhancing oxygen delivery and mu

116 ivation during exercise could interfere with exercise performance by impairing arteriolar dilation in

117 ntrolled trials show that treatment improves exercise performance by increasing lung volume rather th

118 An increase in hemoglobin could enhance exercise performance by increasing oxygen delivery.

119 This may contribute to impaired exercise performance by limiting cardiac output reserve.

120 Sympathetic activation may limit exercise performance by restraining muscle blood flow or

121 This study investigated whether maximal exercise performance can be improved by acutely decreasi

122 Measures of exercise performance can help to further risk stratify p

123 , improve exercise haemodynamics and enhance exercise performance compared to a sham treatment, but l

124 h glucose and fructose can improve endurance exercise performance compared to equivalent amounts of g

125 Exercise performance decreased and was associated with w

126 istic data explaining how iron could augment exercise performance despite minimal changes in hemoglob

127 Exercise performance did not differ between phases [EF:

128 Exercise performance did not differ between quasi-phases

129 On exercise performance, DKO mice show an exaggeration of c

130 LVRS significantly improved exercise performance, due to ventilatory improvements as

131 The aim of this study was to describe exercise performance during the first 2 decades of life

132 at LVRS produces significant improvements in exercise performance, dyspnea, and quality of life in se

133 Functional health status, exercise performance, echocardiographic variables, preva

134 Glycogen depletion minimally affects maximal exercise performance, endurance or ventilation in CHF pa

135 g mL(-1) m(-2)) on quality of life (QOL) and exercise performance (EP) >=1 year after transcatheter a

136 y was to determine quality of life (QOL) and exercise performance (EP) in patients with persistent at

137 During cycle exercise to exhaustion, exercise performance, gas exchange, and respiratory musc

138 The impact of this strategy on exercise performance has not been evaluated.

139 Time-of-day dependent fluctuations in exercise performance have been documented across differe

140 al limitations, yet treatments for improving exercise performance have been elusive.

141 l-characterized, extracardiac limitations to exercise performance have been less well recognized but

142 hydration is prevalent and adversely affects exercise performance; however, its influence on cellular

143 it fatty acid oxidation, increased treadmill exercise performance; however, its long-term efficacy an

144 main physiological determinants of endurance exercise performance (i.e. maximal oxygen consumption ,

145 ngioleiomyomatosis (LAM) is characterized by exercise performance impairment.

146 Exercise performance improved for each participant by an

147 All measures of exercise performance improved similarly in the PRO and C

148 Electrolyte supplementation increased exercise performance, improved maintenance of extracellu

149 We examined aerobic and anaerobic exercise performance in 17 subjects with cystic fibrosis

150 eased skeletal muscle fatigue resistance and exercise performance in a rat model of peripheral artery

151 atory polycythaemia mitigated the decline in exercise performance in acute hypoxia through a higher a

152 The results suggest that curtailment of exercise performance in acute severe hypoxia is due, in

153 Improved endurance exercise performance in adult humans after sprint interv

154 on versus rate control to focus on objective exercise performance in AF and HF shows significant bene

155 may limit cardiovascular reserve and, thus, exercise performance in aged individuals.

156 igated the effect of erythropoietin (EPO) on exercise performance in anemic patients with CHF.

157 ight gain, muscle mass, muscle strength, and exercise performance in BVES-KO mice regardless of sex.

158 afil may be an important agent for improving exercise performance in children and young adults with s

159 ned to increase physical activity levels and exercise performance in children with HCM should account

160 o identify the perioperative determinants of exercise performance in children, adolescents and young

161 n: Reducing inspired gas density can improve exercise performance in COPD as much as increasing inspi

162 The mechanism responsible for diminished exercise performance in cystic fibrosis (CF) is not clea

163 adolescents are limited, and the patterns of exercise performance in different ages are unexplored.

164 culovascular stiffening and improves aerobic exercise performance in healthy aged individuals.

165 lementation has been hypothesized to improve exercise performance in healthy humans through various m

166 travenous verapamil acutely enhances aerobic exercise performance in healthy older individuals in ass

167 nitively clarify any effects of carnitine on exercise performance in healthy persons.

168 does not decrease average muscle strength or exercise performance in healthy, previously untreated su

169 ggesting that pulmonary hypertension impairs exercise performance in heart failure.

170 cise tolerance testing demonstrated impaired exercise performance in heparinized mice; bivalirudin/ar

171 ly16 and Gln27 are associated with depressed exercise performance in HF and represent a genetically d

172 oth males and females, as well as addressing exercise performance in horses and the mechanics of jump

173 ence of systemic RV dysfunction and impaired exercise performance in long-term survivors of the Musta

174 pairments to heart function and whole-animal exercise performance in mahi, underscoring the advantage

175 r atrophy, and it improves grip strength and exercise performance in mdx mice.

176 mage, improved muscle function and increased exercise performance in mdx mice.

177 cle function alleviates dyspnea and improves exercise performance in patients with CHF.

178 GER alone are equally effective in improving exercise performance in patients with COPD.

179 eration of glycogen stores and metabolism on exercise performance in patients with heart failure.

180 ationship between pulmonary hypertension and exercise performance in patients with heart failure.

181 rcise is not by itself a limiting factor for exercise performance in patients with HFpEF.

182 es forearm skeletal muscle bioenergetics and exercise performance in patients with idiopathic palmar

183 ion is widely used in improving symptoms and exercise performance in patients with ischemic heart dis

184 onditioning' with exercise training improves exercise performance in patients with POTS.

185 he hypothesis that NM-702 improves treadmill exercise performance in peripheral arterial disease pati

186 owed that a short-term high-fat diet blunted exercise performance in rats, accompanied by increased u

187 tianginal shown to reduce angina and improve exercise performance in selected patients with early-pos

188 trial, PPoP reduces obstruction and improves exercise performance in severely symptomatic patients wi

189 lood l-lactate is used to assess and monitor exercise performance in sports medicine.

190 hat ventilatory muscle recruitment (VMR) and exercise performance in stable hypercapnic patients woul

191 environments, and studies evaluating aerobic exercise performance in such environments across the men

192 strual cycle phase does not appear to affect exercise performance in the heat in well-trained women,

193 Therapeutic options to improve exercise performance in these patients are limited.

194 The primary problem limiting exercise performance in these patients was the limited v

195 ighttime), the worst hemodynamic profile and exercise performance, increased plasma norepinephrine an

196 Their enhanced exercise performance is consistent with their enhanced c

197 Endurance exercise performance is known to be closely associated w

198 Furthermore, exercise performance is not different across the menstru

199 , and because cardiac function can influence exercise performance, it is the purpose of the present s

200 ances skeletal muscle oxidative capacity and exercise performance, its deletion impairs both paramete

201 r, the time-of-day effects on short duration exercise performance may be minimized by the following f

202 l muscles, and examined the consequences for exercise performance, membrane potentials, contractility

203 Resting blood pressure, CoA gradient, exercise performance, MRI analysis of the aortic arch, a

204 equivocal effects of habitual ACE intake on exercise performance, muscle growth, and risks to bone h

205 ensity exercise training improved muscle and exercise performance, muscle mitochondrial function, and

206 However, physical exercise performance, neither in terms of efficacy nor e

207 mbinant human IL-37 reverses the decrease in exercise performance observed during systemic inflammati

208 ch1 activation improves the regeneration and exercise performance of aged and dystrophic muscles.

209 The purpose of this study was to compare the exercise performance of LVAD patients with that of ambul

210 In addition, impaired treadmill exercise performance of male Pompe mice was improved.

211 he patients but not the claudication-limited exercise performance of the patients.

212 istance to diet-induced obesity and impaired exercise performance on a treadmill.

213 rt failure (cardiac dysfunction and impaired exercise performance) on optimal current therapy (97% en

214 erted a statistically significant benefit on exercise performance or frequency of ischemia during amb

215 e any clinically significant improvements in exercise performance or perceptions of dyspnea during ex

216 Rifalazil did not improve exercise performance or quality of life in patients with

217 f AdVEGF121 was not associated with improved exercise performance or quality of life in this study.

218 , pulmonary function, maximal and submaximal exercise performance or quality-of-life questionnaires w

219 e estimation of VO(2max) based on submaximal exercise performance or somatic variables.

220 Dehydration can negatively impact exercise performance, overall health, and cognitive func

221 ion of Rev-erba results in global changes in exercise performance, oxidative capacity, and blood gluc

222 Maximal exercise performance (peak oxygen consumption), muscle p

223 Strong correlations between overall exercise performance (percent predicted VO2max and maxim

224 ith greater biventricular enlargement, worse exercise performance, poorer quality of life, and higher

225 Strong correlations between overall exercise performance (% predicted VO2max) and indices of

226 dy glycogen synthesis and impairs subsequent exercise performance, presumably because of lower hepati

227 cal summary score was associated with poorer exercise performance (R(2) adjusted = 0.20; p < 0.001; n

228 artery function, exercise haemodynamics and exercise performance relative to knee extension (KE) exe

229 teristics of left ventricular unloading, and exercise performance remains largely unstudied.

230 Exercise performance remains limited in some patients af

231 , the full extent of mavacamten's effects on exercise performance remains unclear.

232 Optimal exercise performance requires an integrated physiologic

233 Maximal and submaximal exercise performance, respiratory and quadriceps muscle

234 rinsing with a 6.4% maltodextrin solution on exercise performance, showing it to significantly reduce

235 elated to the extent of EICR or the level of exercise performance, suggesting a nonphysiological natu

236 jor determinants of central motor output and exercise performance switches from a predominantly perip

237 , women were more symptomatic and had poorer exercise performance than men.

238 re older and more symptomatic and had poorer exercise performance than men.

239 in cardiovascular structure and function and exercise performance that have been reported previously

240 The results suggest that the improvement in exercise performance that is observed when carbohydrate

241 plasma glucose concentrations and decreased exercise performance the next day.Mixed meals containing

242 monotherapy was well tolerated and increased exercise performance throughout its dosing interval at a

243 This suggests that short-duration maximal exercise performance throughout the day is controlled no

244 (aO(2)) on locomotor muscle power output and exercise performance time is determined to a significant

245 s study tested whether HD-tDCS would improve exercise performance to a greater extent than convention

246 -term temperature challenge affected aerobic exercise performance (U(crit)), but each T(E) group had

247 termines the maintenance of muscle force and exercise performance upon a HFD regimen.

248 Treadmill exercise performance was also studied.

249 Exercise performance was assessed by peak exercise oxyge

250 Before and after the training period, exercise performance was assessed by using repeated spri

251 Poor exercise performance was due primarily to ventilatory li

252 The short-term impact of LVRS on exercise performance was evaluated using maximal and sub

253 Exercise performance was impaired in patients when compa

254 xpressed, diastolic function was normalized, exercise performance was improved, and pathological hype

255 Exercise performance was limited (work load, 68% +/- 6)

256 Similar correlations were found when exercise performance was measured by maximal workload ac

257 of regular physical activity, their maximal exercise performance was reduced and was associated with

258 Exercise performance was severely limited in both subgro

259 values for the fasting and wheat trials, but exercise performance was unaffected.

260 bsence of abdominal wall musculature impairs exercise performance we studied nine patients 6 to 31 yr

261 d pressure, residual aortic obstruction, and exercise performance were evaluated.

262 pometric characteristics, lung function, and exercise performance were similar for the 22 patients in

263 keletal muscle oxidative capacity, enhancing exercise performance when activated.

264 e of HF + COPD induces greater impairment on exercise performance when compared to patients without o

265 dies of Asian ginsengs found improvements in exercise performance when most of the following conditio

266 Higher O(2) pulse is associated with better exercise performance, whereas adolescence and male gende

267 ARbeta/delta mice are known to have enhanced exercise performance, whereas MCK-PPARalpha mice perform

268 eview, we describe changes in peak endurance exercise performance with advancing age as well as physi

269 d left ventricular myocardial energetics and exercise performance without demonstrable effects on sym